Literature DB >> 14646409

46,XY phenotypic male with focal segmental glomerulosclerosis caused by the WT1 splice site mutation.

Toshihiro Tajima1, Satoshi Sasaki, Yayoi Tanaka, Hiroyuki Kusunoki, Testuro Nagashima, Katsuya Nonomura, Kenji Fujieda.   

Abstract

OBJECTIVE: Frasier syndrome is characterized by progressive glomerulopathy due to nonspecific focal and segmental glomerulosclerosis (FSGS), 46,XY sex reversal and the development of gonadoblastoma from dysgenetic gonads. Donor splice site heterozygous mutations in intron 9 of the Wilms' tumor gene (WT1) cause this disease. We investigated whether WT1 mutations showed clinical heterogeneity. PATIENTS AND METHODS: A 6-year-old phenotypic boy was diagnosed as having FSGS. His karyotype was 46,XY. Gonadotropin-releasing hormone and human chorionic gonadotropin stimulation tests revealed normal luteinizing hormone, follicle-stimulating hormone and testosterone responses. The other patient was a 7-year-old 46,XY female with FSGS. Prophylactic gonadectomy was performed and gonadoblastoma was found. By polymerase chain reaction and direct sequencing, WT1 was analyzed in these patients. RESULTS AND
CONCLUSION: Both patients had IVS9 + 5G-->A in intron 9 of the WT1. Our study indicates a normal 46,XY phenotypic male patient with FSGS. The phenotypic variations of the WT1 splice site mutations are further expanded. Copyright 2003 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14646409     DOI: 10.1159/000074249

Source DB:  PubMed          Journal:  Horm Res        ISSN: 0301-0163


  9 in total

1.  Genotype/phenotype correlation in nephrotic syndrome caused by WT1 mutations.

Authors:  Gil Chernin; Virginia Vega-Warner; Dominik S Schoeb; Saskia F Heeringa; Bugsu Ovunc; Pawaree Saisawat; Roxana Cleper; Fatih Ozaltin; Friedhelm Hildebrandt
Journal:  Clin J Am Soc Nephrol       Date:  2010-07-01       Impact factor: 8.237

2.  WT1 intron 9 splice acceptor site mutation in a 46,XY male with focal segmental glomerulosclerosis.

Authors:  Katsuyoshi Kanemoto; Kenji Ishikura; Daisuke Ariyasu; Yuko Hamasaki; Hiroshi Hataya; Yukihiro Hasegawa; Masahiro Ikeda
Journal:  Pediatr Nephrol       Date:  2006-10-24       Impact factor: 3.714

Review 3.  WT1 and glomerular diseases.

Authors:  Patrick Niaudet; Marie-Claire Gubler
Journal:  Pediatr Nephrol       Date:  2006-08-23       Impact factor: 3.714

4.  Frasier syndrome: early gonadoblastoma and cyclosporine responsiveness.

Authors:  Aditi Sinha; Sonika Sharma; Ashima Gulati; Alok Sharma; Sandeep Agarwala; Pankaj Hari; Arvind Bagga
Journal:  Pediatr Nephrol       Date:  2010-04-24       Impact factor: 3.714

5.  WT1 and NPHS2 mutations in Korean children with steroid-resistant nephrotic syndrome.

Authors:  Hee Yeon Cho; Joo Hoon Lee; Hyun Jin Choi; Bum Hee Lee; Il Soo Ha; Yong Choi; Hae Il Cheong
Journal:  Pediatr Nephrol       Date:  2007-10-13       Impact factor: 3.714

6.  Correct dosage of Fog2 and Gata4 transcription factors is critical for fetal testis development in mice.

Authors:  Gerrit J Bouma; Linda L Washburn; Kenneth H Albrecht; Eva M Eicher
Journal:  Proc Natl Acad Sci U S A       Date:  2007-09-11       Impact factor: 11.205

7.  Gonadal Function in 15 Patients Associated with WT1 Gene Mutations.

Authors:  Akiko Maesaka; Asako Higuchi; Shinobu Kotoh; Yukihiro Hasegawa; Masahiro Ikeda; Seiichirou Shishido; Masataka Honda
Journal:  Clin Pediatr Endocrinol       Date:  2006-11-03

8.  Systematic Review of Genotype-Phenotype Correlations in Frasier Syndrome.

Authors:  Yurika Tsuji; Tomohiko Yamamura; China Nagano; Tomoko Horinouchi; Nana Sakakibara; Shinya Ishiko; Yuya Aoto; Rini Rossanti; Eri Okada; Eriko Tanaka; Koji Tsugawa; Takayuki Okamoto; Toshihiro Sawai; Yoshinori Araki; Yuko Shima; Koichi Nakanishi; Hiroaki Nagase; Masafumi Matsuo; Kazumoto Iijima; Kandai Nozu
Journal:  Kidney Int Rep       Date:  2021-07-16

Review 9.  Molecular Mechanisms of Proteinuria in Focal Segmental Glomerulosclerosis.

Authors:  Yumeng Wen; Sapna Shah; Kirk N Campbell
Journal:  Front Med (Lausanne)       Date:  2018-04-16
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.